Penn Medicine researchers found two oral drugs eliminated dormant breast cancer cells in most patients, with relapse rates ...

We recently compiled a list of the 12 Best Performing Healthcare Stocks to Buy Right Now. Celcuity Inc. is one of them.

A drug that costs 5p per tablet and is already widely used to treat malaria may also cut the chances of breast cancer ...

The emergence of drug resistance remains one of the greatest challenges in effective cancer therapy. Despite advances in ...

Phosphoproteomic profiling of Osimertinib drug-tolerant persister (DTP) cells identified dynamic signaling transitions and ...

Animal studies say rapamycin can slow aging – but does it work in humans? A new review finds the evidence for the off-label, ...

Kazia Therapeutics Limited (NASDAQ: KZIA), a clinical-stage biotechnology company developing innovative therapies for ...

Sapu003 Designed to Overcome Limitations of Afinitor®, FDA-Approved Oral Everolimus, Delivering Full Strength of Everolimus ...

Primary liver cancer is the third leading cause of cancer-related deaths, of which hepatocellular carcinoma (HCC) accounts for approximately 90% of all liver cancer cases. Given that the development ...

A large cohort study adds evidence that nicotinamide can prevent skin cancer in patients with previous skin cancers and solid ...

Cancer cachexia is a complex metabolic syndrome characterized by the ongoing loss of skeletal muscle mass, with or without fat loss, that cannot be reversed entirely by conventional nutritional ...

Spending on healthcare in the US is predicted to hit $5.3 trillion this year, making it one of the largest in the world.